122 related articles for article (PubMed ID: 15363939)
21. Isolation and cultivation of Plasmodium falciparum using adult bovine serum.
Divo AA; Vande Waa JA; Campbell JR; Jensen JB
J Parasitol; 1985 Aug; 71(4):504-9. PubMed ID: 3897502
[TBL] [Abstract][Full Text] [Related]
22. Validation of a Plasmodium falciparum parasite transformed with green fluorescent protein for antimalarial drug screening.
Sanchez BA; Varotti FP; Rodrigues FG; Carvalho LH
J Microbiol Methods; 2007 Jun; 69(3):518-22. PubMed ID: 17466399
[TBL] [Abstract][Full Text] [Related]
23. [Successful in vitro culture of Plasmodium falciparum gametocytes].
Rada AM; Moreno C; Blair S
Biomedica; 2008 Dec; 28(4):607-15. PubMed ID: 19462566
[TBL] [Abstract][Full Text] [Related]
24. Molecular epidemiology of malaria in cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum.
Basco LK
Am J Trop Med Hyg; 2004 May; 70(5):474-80. PubMed ID: 15155978
[TBL] [Abstract][Full Text] [Related]
25. Effect of metalloprotease inhibitors on invasion of red blood cell by Plasmodium falciparum.
Kitjaroentham A; Suthiphongchai T; Wilairat P
Acta Trop; 2006 Jan; 97(1):5-9. PubMed ID: 16168946
[TBL] [Abstract][Full Text] [Related]
26. Effects of neoglycoproteins on penetration of Plasmodium falciparum merozoites into erythrocytes in vitro.
Schulman S; Lee YC; Vanderberg JP
J Parasitol; 1984 Apr; 70(2):213-6. PubMed ID: 6381683
[TBL] [Abstract][Full Text] [Related]
27. Antimalarial activity of crambescidin 800 and synthetic analogues against liver and blood stage of Plasmodium sp.
Lazaro JE; Nitcheu J; Mahmoudi N; Ibana JA; Mangalindan GC; Black GP; Howard-Jones AG; Moore CG; Thomas DA; Mazier D; Ireland CM; Concepcion GP; Murphy PJ; Diquet B
J Antibiot (Tokyo); 2006 Sep; 59(9):583-90. PubMed ID: 17136890
[TBL] [Abstract][Full Text] [Related]
28. Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites.
Gilson PR; Crabb BS
Int J Parasitol; 2009 Jan; 39(1):91-6. PubMed ID: 18952091
[TBL] [Abstract][Full Text] [Related]
29. New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'.
Valla A; Valla B; Cartier D; Le Guillou R; Labia R; Florent L; Charneau S; Schrevel J; Potier P
Eur J Med Chem; 2006 Jan; 41(1):142-6. PubMed ID: 16274873
[TBL] [Abstract][Full Text] [Related]
30. [Plasmodium falciparum: interpretation of the semi-microtest of in vitro chemosensitivity by H3-hypoxanthine incorporation].
Le Bras J; Andrieu B; Hatin I; Savel J; Coulaud JP
Pathol Biol (Paris); 1984 May; 32(5):463-6. PubMed ID: 6377209
[TBL] [Abstract][Full Text] [Related]
31. Disruption of lipid rafts by lidocaine inhibits erythrocyte invasion by Plasmodium falciparum.
Koshino I; Takakuwa Y
Exp Parasitol; 2009 Dec; 123(4):381-3. PubMed ID: 19733566
[TBL] [Abstract][Full Text] [Related]
32. Absence of effect of retinol on the in vitro development of Plasmodium falciparum.
Samba DC; Basco LK; Bleiberg-Daniel F; Lemmonier D; Le Bras J
Int J Vitam Nutr Res; 1992; 62(1):99-100. PubMed ID: 1587714
[No Abstract] [Full Text] [Related]
33. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
Jung SY; Zheng B; Choi YY; Soh BY; Kim SY; Park KI; Park H
Arch Pharm Res; 2009 Jun; 32(6):899-906. PubMed ID: 19557368
[TBL] [Abstract][Full Text] [Related]
34. Synergistic enhancement of a copper chelator, bathocuproine disulphonate, and cysteine on in vitro growth of Plasmodium falciparum in glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Tantular IS; Jalloh A; Pusarawati S; Azuno Y; Lin K; Kerong H; Dachlan YP; Ishii A; Kawamoto F
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):301-9. PubMed ID: 12971554
[TBL] [Abstract][Full Text] [Related]
35. An improved and highly sensitive microfluorimetric method for assessing susceptibility of Plasmodium falciparum to antimalarial drugs in vitro.
Quashie NB; de Koning HP; Ranford-Cartwright LC
Malar J; 2006 Oct; 5():95. PubMed ID: 17076900
[TBL] [Abstract][Full Text] [Related]
36. Plasmodium falciparum: growth response to potassium channel blocking compounds.
Waller KL; Kim K; McDonald TV
Exp Parasitol; 2008 Nov; 120(3):280-5. PubMed ID: 18703053
[TBL] [Abstract][Full Text] [Related]
37. In vitro efficiency of new acridyl derivatives against Plasmodium falciparum.
Guetzoyan L; Ramiandrasoa F; Dorizon H; Desprez C; Bridoux A; Rogier C; Pradines B; Perrée-Fauvet M
Bioorg Med Chem; 2007 May; 15(9):3278-89. PubMed ID: 17339112
[TBL] [Abstract][Full Text] [Related]
38. Antimalarial action of hydrophilic drugs: involvement of aqueous access routes to intracellular parasites.
Loyevsky M; Cabantchik ZI
Mol Pharmacol; 1994 Mar; 45(3):446-52. PubMed ID: 8145731
[TBL] [Abstract][Full Text] [Related]
39. Antimalarial activity of anthothecol derived from Khaya anthotheca (Meliaceae).
Lee SE; Kim MR; Kim JH; Takeoka GR; Kim TW; Park BS
Phytomedicine; 2008 Jun; 15(6-7):533-5. PubMed ID: 17913482
[TBL] [Abstract][Full Text] [Related]
40. Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents.
Andricopulo AD; Akoachere MB; Krogh R; Nickel C; McLeish MJ; Kenyon GL; Arscott LD; Williams CH; Davioud-Charvet E; Becker K
Bioorg Med Chem Lett; 2006 Apr; 16(8):2283-92. PubMed ID: 16458512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
